Ewelina Dratkiewicz

Characterization of Melanoma Cell Lines Resistant to Vemurafenib and Evaluation of Their Responsiveness to EGFR- and MET-Inhibitor Treatment

Ewelina Dratkiewicz, Aleksandra Simiczyjew, Katarzyna Pietraszek‐Gremplewicz et al. · International Journal of Molecular Sciences · 2019 · 51 citations · Full text

Met-inhibitor Treatment, Their Responsiveness, Skin Cancer +14

Melanoma cells with diverse invasive potential differentially induce the activation of normal human fibroblasts

Justyna Mazurkiewicz, Aleksandra Simiczyjew, Ewelina Dratkiewicz et al. · Cell Communication and Signaling · 2022 · 44 citations · Full text

Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines

Aleksandra Simiczyjew, Ewelina Dratkiewicz, Marleen Van Troys et al. · Cancers · 2018 · 32 citations · Full text

Breast Oncology, Oncology, Endocrine-related Cancer +15

The effect of the lamin A and its mutants on nuclear structure, cell proliferation, protein stability, and mobility in embryonic cells

Katarzyna Piekarowicz, Magdalena Machowska, Ewelina Dratkiewicz et al. · Chromosoma · 2016 · 28 citations · Full text

Expression level of EGFR and MET receptors regulates invasiveness of melanoma cells

Katarzyna Pietraszek‐Gremplewicz, Aleksandra Simiczyjew, Ewelina Dratkiewicz et al. · Journal of Cellular and Molecular Medicine · 2019 · 25 citations · Full text